BACKGROUND: clinical isolates in Iran and to report an overall prevalence. METHODS: ", "ESBLs", "CTX-M" and "Iran" were searched in PubMed, Scopus, EBSCO, Google Scholar, Scirus, SID and IranMedex in both English and Persian. Selected articles were published between July 2010 and July 2016 and all of them were in English. STATA SE version 11.0 was used for statistical analysis. RESULTS: clinical isolates varied from 7.7% in Tabriz to 100% in Mashhad, Tehran, and Zahedan, with an overall RF of 56.7%. CONCLUSION: is diverse in different regions of Iran, and the central and eastern regions had higher prevalence rates compared to western regions.
No takes yet. Share an insight, caveat, or question.
Eskandari‐Nasab et al. (2018) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: